2-54599119-C-T
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PS1_ModeratePM1PM2PM5PP2PP3_ModeratePP5_Moderate
The NM_003128.3(SPTBN1):c.176C>T(p.Thr59Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T59S) has been classified as Pathogenic.
Frequency
Consequence
NM_003128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPTBN1 | NM_003128.3 | c.176C>T | p.Thr59Ile | missense_variant | 3/36 | ENST00000356805.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPTBN1 | ENST00000356805.9 | c.176C>T | p.Thr59Ile | missense_variant | 3/36 | 1 | NM_003128.3 | P1 | |
SPTBN1 | ENST00000333896.5 | c.137C>T | p.Thr46Ile | missense_variant | 2/31 | 1 | |||
SPTBN1 | ENST00000389980.7 | c.176C>T | p.Thr59Ile | missense_variant | 3/14 | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Developmental delay, impaired speech, and behavioral abnormalities Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center | Sep 02, 2021 | The c.176C>T variant is a heterozygous single base pair substitution at nucleotide 176 in exon 3 of 36 of the SPTBN1 gene, resulting in a substitution of a highly conserved threonine at amino acid position 59 to a isoleucine (p.Thr59Ile). This variant is absent from the gnomAD database, indicating it is not a common benign occurrence in the populations represented in these databases. This variant is predicted to damage protein structure and/or function based on in silico algorithms (PolyPhen2, SIFT, DANN). The SPTBN1 gene encodes neuronal beta-II spectrin, the most abundant beta-spectrin in the brain and a subunit of spectrin. Spectrins are components of the cytoskeleton and allow proper localization of essential membrane proteins, signal transduction and cellular scaffolding through the binding of cytoskeletal elements and the plasma membrane (PMID: 33847457). The threonine at position 59 falls in the calponin homology domain 1 (CH1) conserved region, which is essential for proper interaction with actin (PMID: 34211179). Heterozygous pathogenic variants in SPTBN1 have recently been linked to developmental delay, impaired speech, and behavioral abnormalities. Both missense and truncating variants have been reported to be associated with this phenotype (PMIDs: 33847457, 34211179). Functional studies on the p.Thr59Ile variant were completed by Cousin et al (PMID: 34211179). In vitro functional expression studies in HEK293 cells transfected with the p.Thr59Ile variant demonstrated reduced protein levels relative to control. In addition, a cosedimentation assay demonstrated that the p.Thr59Ile variant reduced F-actin binding. Studies of cortical neurons derived from Sptbn1-null mice showed impaired organization of the axon initial segment (AIS) with reduced axonal growth, dendritic abnormalities, and aberrant lysosome dynamics. These defects could not be fully rescued by expression of the protein containing the p.Thr59Ile variant, suggesting pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.